Operating Lease, Right-of-Use Asset of Autolus Therapeutics plc from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Autolus Therapeutics plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Autolus Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $56,625,000, a 6.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $56,625,000 -$3,878,000 -6.4% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $58,619,000 +$941,000 +1.6% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $56,250,000 -$2,876,000 -4.9% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $55,498,000 -$5,293,000 -8.7% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $60,503,000 +$1,100,000 +1.9% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $57,678,000 +$3,427,000 +6.3% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $59,126,000 +$32,265,000 +120% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 $60,791,000 +$37,581,000 +162% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $59,403,000 +$46,168,000 +349% 30 Sep 2023 10-K 21 Mar 2024 2023 FY
Q2 2023 $54,251,000 +$39,021,000 +256% 30 Jun 2023 10-K 21 Mar 2024 2023 FY
Q1 2023 $26,861,000 +$9,495,000 +55% 31 Mar 2023 10-K 21 Mar 2024 2023 FY
Q4 2022 $23,210,000 +$4,435,000 +24% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $13,235,000 30 Sep 2022 10-K 21 Mar 2024 2023 FY
Q2 2022 $15,230,000 30 Jun 2022 10-K 21 Mar 2024 2023 FY
Q1 2022 $17,366,000 -$3,833,000 -18% 31 Mar 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $18,775,000 -$32,862,000 -64% 31 Dec 2021 20-F 07 Mar 2023 2022 FY
Q1 2021 $21,199,000 -$2,514,000 -11% 31 Mar 2021 6-K 06 May 2021 2021 Q1
Q4 2020 $51,637,000 +$28,228,000 +121% 31 Dec 2020 20-F 10 Mar 2022 2021 FY
Q3 2020 $49,535,000 +$25,402,000 +105% 30 Sep 2020 6-K 05 Nov 2020 2020 Q3
Q2 2020 $25,100,000 -$405,000 -1.6% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q1 2020 $23,713,000 31 Mar 2020 6-K 07 May 2020 2020 Q1
Q4 2019 $23,409,000 +$17,809,000 +318% 31 Dec 2019 20-F 04 Mar 2021 2020 FY
Q3 2019 $24,133,000 30 Sep 2019 6-K 07 Nov 2019 2019 Q3
Q2 2019 $25,505,000 30 Jun 2019 6-K 08 Aug 2019 2019 Q2
Q4 2018 $5,600,000 01 Jan 2019 20-F 03 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.